Javascript must be enabled to continue!
Lipid-mediated reinforcement of FGF/MAPK signaling enables robust otic placode specification
View through CrossRef
Abstract
The formation of cranial placodes requires groups of ectodermal cells to interpret inductive signals in a robust and organized manner, yet how signaling responses are coordinated across a developing field remains incompletely understood. During otic placode specification, fibroblast growth factor (FGF) signaling must overcome intrinsic noise and rising inhibitory feedback to drive collective transcriptional responses, suggesting the existence of reinforcing regulatory events beyond ligand–receptor interactions and gene regulatory networks alone. Here we identify the secreted lipid-binding protein Apolipoprotein D (APOD) as an essential mediator of otic placode specification that links lipid-dependent regulation to FGF/MAPK signaling during early development. We find that
APOD
is strongly expressed in the forming otic placode, where it is necessary for otic specification and morphogenesis. Loss of APOD attenuates ERK1/2 activation, indicating impaired cellular responsiveness to FGF/MAPK signaling. Notably, FGF signaling induces
APOD
expression, establishing a positive feedback loop that reinforces signaling at the tissue level. These findings reveal lipid-mediated regulation of cell signaling as a critical mechanism enabling robust interpretation of developmental signals during sensory placode formation. More broadly, our work highlights lipid management as a key organizational principle by which embryonic tissues achieve coordinated responses to morphogenetic cues.
Highlights
The lipocalin Apolipoprotein D (APOD) is expressed transiently during early otic development
APOD is required for specification and morphogenesis of the otic placode
APOD functions upstream MAPK activation during otic specification
FGF induces
APOD
expression to build a positive feedback loop
Graphical Abstract
Title: Lipid-mediated reinforcement of FGF/MAPK signaling enables robust otic placode specification
Description:
Abstract
The formation of cranial placodes requires groups of ectodermal cells to interpret inductive signals in a robust and organized manner, yet how signaling responses are coordinated across a developing field remains incompletely understood.
During otic placode specification, fibroblast growth factor (FGF) signaling must overcome intrinsic noise and rising inhibitory feedback to drive collective transcriptional responses, suggesting the existence of reinforcing regulatory events beyond ligand–receptor interactions and gene regulatory networks alone.
Here we identify the secreted lipid-binding protein Apolipoprotein D (APOD) as an essential mediator of otic placode specification that links lipid-dependent regulation to FGF/MAPK signaling during early development.
We find that
APOD
is strongly expressed in the forming otic placode, where it is necessary for otic specification and morphogenesis.
Loss of APOD attenuates ERK1/2 activation, indicating impaired cellular responsiveness to FGF/MAPK signaling.
Notably, FGF signaling induces
APOD
expression, establishing a positive feedback loop that reinforces signaling at the tissue level.
These findings reveal lipid-mediated regulation of cell signaling as a critical mechanism enabling robust interpretation of developmental signals during sensory placode formation.
More broadly, our work highlights lipid management as a key organizational principle by which embryonic tissues achieve coordinated responses to morphogenetic cues.
Highlights
The lipocalin Apolipoprotein D (APOD) is expressed transiently during early otic development
APOD is required for specification and morphogenesis of the otic placode
APOD functions upstream MAPK activation during otic specification
FGF induces
APOD
expression to build a positive feedback loop
Graphical Abstract.
Related Results
Expression of osteoclastogenic factor transcripts in osteoblast‐like UMR‐106 cells after exposure to FGF‐23 or FGF‐23 combined with parathyroid hormone
Expression of osteoclastogenic factor transcripts in osteoblast‐like UMR‐106 cells after exposure to FGF‐23 or FGF‐23 combined with parathyroid hormone
AbstractAs a bone‐derived hormone, fibroblast growth factor‐23 (FGF‐23) negatively regulates phosphate and calcium metabolism, while retaining growth‐promoting action for mesenchym...
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract
Oncogenically activated RAS-MAPK pathway is the driver of several cancers including the majority of non-small cell lung adenocarcinomas (NSCLC). RAS-MAPK pa...
Rnf149-related
is an FGF/MAPK-independent regulator of pharyngeal muscle fate specification
Rnf149-related
is an FGF/MAPK-independent regulator of pharyngeal muscle fate specification
Abstract
During embryonic development, cell fate specification gives rise to dedicated lineages that underlie tissue formation. In olfactores, wh...
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Negative Regulation by p70 S6 Kinase of FGF-2–Stimulated VEGF Release Through Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase in Osteoblasts
Abstract
To clarify the mechanism of VEGF release in osteoblasts, we studied whether p70 S6 kinase is involved in basic FGF-2–stimulated VEGF release in osteoblast-l...
A pleiotropic role for FGF signaling in mammary gland stromal fibroblasts
A pleiotropic role for FGF signaling in mammary gland stromal fibroblasts
Abstract
Fibroblast growth factor (FGF) signaling is crucial for mammary gland development. While multiple roles for FGF signaling in the epithelium were described,...
Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
Primary cilium drives the left-right asymmetry process during embryonic development. Moreover, its dysregulation contributes to cancer progression by affecting various signaling pa...
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism
Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism
We investigated how lipid raft association of HSPG (heparan sulphate proteoglycans) modulates FGF-2 (fibroblast growth factor-2/basic fibroblast growth factor) interactions with va...
RETROGRADE CORONARY VENOUS DELIVERY OF FIBROBLAST GROWTH FACTOR-2 ENHANCES IN VIVO HOMING AND DIFFERENTIATION OF MESENCHYMAL STEM CELLS
RETROGRADE CORONARY VENOUS DELIVERY OF FIBROBLAST GROWTH FACTOR-2 ENHANCES IN VIVO HOMING AND DIFFERENTIATION OF MESENCHYMAL STEM CELLS
Objectives
In vitro studies showed fibroblast growth factor-2 (FGF-2) controls migration of mesenchymal stem cells (MSCs). In the present study, we established co...

